Literature DB >> 17346363

Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments.

Constantine G Lyketsos1.   

Abstract

Neuropsychiatric symptoms (NPS) are central features of dementia and an important treatment target. They should be assessed in future studies of emerging dementia therapies, using appropriate measures matched to the purpose of each study. Several significant issues remain regarding (1) the classification of these symptoms into syndromes, and (2) the development of better clinical measures for their quantification. In particular, effort should be directed at assessing their evolution over shorter time periods, and at using more objective methods in their measurement, such as actigraphy. These issues can be solved with nosologic study and other advances that could be brought about quickly, if appropriate time and effort are allocated. Empirical characterization of clinically meaningful change in NPS--by examining their relationship with dementia care burden, disability, quality of life, caregiver distress, and resource utilization--would be an important advance.

Entities:  

Mesh:

Year:  2007        PMID: 17346363     DOI: 10.1017/S104161020700484X

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  25 in total

Review 1.  Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Authors:  Celina S Liu; Sarah A Chau; Myuri Ruthirakuhan; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

2.  Behavioral symptoms of dementia: a dyadic effect of caregivers' stress process?

Authors:  Judy L M Campbell; Meredeth A Rowe; Michael Marsiske
Journal:  Res Gerontol Nurs       Date:  2010-09-30       Impact factor: 1.571

3.  When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer's disease.

Authors:  Carol E Franz; Judith C Barker; Kathleen Kim; Yvette Flores; Cecily Jenkins; Richard L Kravitz; Ladson Hinton
Journal:  Am J Geriatr Psychiatry       Date:  2010-07       Impact factor: 4.105

4.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

Review 5.  Simulated presence therapy for dementia.

Authors:  Iosief Abraha; Joseph M Rimland; Isabel Lozano-Montoya; Giuseppina Dell'Aquila; Manuel Vélez-Díaz-Pallarés; Fabiana M Trotta; Alfonso J Cruz-Jentoft; Antonio Cherubini
Journal:  Cochrane Database Syst Rev       Date:  2017-04-18

6.  Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia.

Authors:  Sarah N Forrester; Joseph J Gallo; Gwenn S Smith; Jeannie-Marie S Leoutsakos
Journal:  Am J Geriatr Psychiatry       Date:  2015-05-16       Impact factor: 4.105

7.  The physical environment influences neuropsychiatric symptoms and other outcomes in assisted living residents.

Authors:  Mark C Bicket; Quincy M Samus; Mathew McNabney; Chiadi U Onyike; Lawrence S Mayer; Jason Brandt; Peter Rabins; Constantine Lyketsos; Adam Rosenblatt
Journal:  Int J Geriatr Psychiatry       Date:  2010-10       Impact factor: 3.485

8.  Neuropsychiatric Symptoms in Dementia: Overview and Measurement Challenges.

Authors:  C G Lyketsos
Journal:  J Prev Alzheimers Dis       Date:  2015-09

Review 9.  Management of agitation and aggression associated with Alzheimer disease.

Authors:  Clive G Ballard; Serge Gauthier; Jeffrey L Cummings; Henry Brodaty; George T Grossberg; Philippe Robert; Constantine G Lyketsos
Journal:  Nat Rev Neurol       Date:  2009-05       Impact factor: 42.937

10.  Prevalence and treatment of neuropsychiatric symptoms in advanced dementia.

Authors:  Karan S Kverno; Peter V Rabins; David M Blass; Kathryn L Hicks; Betty S Black
Journal:  J Gerontol Nurs       Date:  2008-12       Impact factor: 1.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.